Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease

被引:0
|
作者
Siriwan Sakarin
Anudep Rungsipipat
Sirilak Disatian Surachetpong
机构
[1] Chulalongkorn University,Department of Veterinary Medicine, Faculty of Veterinary Science
[2] Chulalongkorn University,Companion Animal Cancer Research Unit, Department of Veterinary Pathology, Faculty of Veterinary Science
来源
Veterinary Research Communications | 2023年 / 47卷
关键词
Inflammatory cells; Medial thickening; Myxomatous mitral valve disease; Pulmonary artery; Pulmonary hypertension;
D O I
暂无
中图分类号
学科分类号
摘要
Pulmonary hypertension (PH), an increase in pulmonary arterial pressure (PAP), may occur in dogs affected with myxomatous mitral valve disease (MMVD). Recent studies suggest that an accumulation of perivascular inflammatory cells may be involved with medial thickening which is a sign of the pulmonary artery remodelling in PH. The aim of this study was to characterise perivascular inflammatory cells in the surrounding pulmonary arteries of dogs with PH due to MMVD compared to MMVD dogs and healthy control dogs. Nineteen lung samples were collected from cadavers of small-breed dogs (control n = 5; MMVD n = 7; MMVD + PH n = 7). Toluidine blue stain and multiple IHC targeting α-SMA, vWF, CD20, CD68 and CD3 was performed to examine intimal and medial thickening, assess muscularisation of the small pulmonary arteries and characterise perivascular leucocytes. Medial thickening without intimal thickening of pulmonary arteries and muscularisation of normally non-muscularised small pulmonary arteries was observed in the MMVD and MMVD + PH groups compared with the control group. The perivascular numbers of B lymphocytes, T lymphocytes and macrophages was significantly increased in the MMVD + PH group compared with the MMVD and control groups. In contrast, the perivascular number of mast cells was significantly higher in the MMVD group compared with the MMVD + PH and control groups. This study suggested that pulmonary artery remodelling as medial thickening and muscularisation of the normally non-muscular small pulmonary arteries is accompanied by the accumulation of perivascular inflammatory cells.
引用
收藏
页码:1505 / 1521
页数:16
相关论文
共 50 条
  • [21] The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease (vol 7, 612130, 2020)
    Sakarin, Siriwan
    Surachetpong, Sirilak Disatian
    Rungsipipat, Anudep
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [22] Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
    Udomkiattikul, Jutamas
    Kirdratanasak, Noppasorn
    Siritianwanitchakul, Panatsada
    Worapunyaanun, Wasaporn
    Surachetpong, Sirilak Disatian
    INTERNATIONAL JOURNAL OF VETERINARY SCIENCE AND MEDICINE, 2022, 10 (01) : 25 - 32
  • [23] Short-term effects of sildenafil in the treatment of dogs with pulmonary hypertension secondary to degenerative mitral valve disease
    Saetang, Karun
    Surachetpong, Sirilak Disatian
    VETERINARY WORLD, 2020, 13 (10) : 2260 - 2268
  • [24] Cardiomyocyte marker expression in dogs with left atrial enlargement due to dilated cardiomyopathy or myxomatous mitral valve disease
    Janus, Izabela
    Kandefer-Gola, Malgorzata
    Ciaputa, Rafal
    Noszczyk-Nowak, Agnieszka
    Paslawska, Urszula
    Tursi, Massimiliano
    Nowak, Marcin
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2017, 55 (02) : 52 - 61
  • [25] Long-term effect of low-dose imatinib therapy for pulmonary hypertension due to chronic degenerative mitral valve disease in six dogs
    Leong, Zi Ping
    Arita, Shinji
    Hikasa, Yoshiaki
    THAI JOURNAL OF VETERINARY MEDICINE, 2018, 48 (03): : 499 - 505
  • [26] Investigation of Genes and Proteins Expression Associating Serotonin Signaling Pathway in Lung and Pulmonary Artery Tissues of Dogs with Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease: The Preliminary Study
    Tangmahakul, Nattawan
    Sakarin, Siriwan
    Techangamsuwan, Somporn
    Rungsipipat, Anudep
    Surachetpong, Sirilak Disatian
    VETERINARY SCIENCES, 2022, 9 (10)
  • [27] Pulmonary hypertension due to left heart disease with pulmonary arterial wedge pressure ≤15mmHg
    Xu, Dongxu
    Zhang, Hao
    Cheng, Huiling
    Xu, Tianbao
    Sun, Wei
    Sheng, Yanhui
    Yang, Rong
    Xu, Dongjie
    Zhou, Fang
    Zhou, Yanli
    Xu, Fang
    Zhu, Hongyan
    Cheang, IokFai
    Ding, Qiang
    Chen, Yan
    Zhao, Pei
    Kong, Xiangqing
    Li, Xinli
    Zhang, Haifeng
    HERZ, 2021, 46 : 209 - 214
  • [28] Metabolic gene therapy in a canine with pulmonary hypertension secondary to degenerative mitral valve disease
    Katz, Michael G.
    Ohad, Dan G.
    Putter, Philip
    Shtraizent, Nataly
    Shahar, Ehud
    Tal, Smadar
    Eliyahu, Efrat
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [29] The Association Between Post-Operative Pulmonary Hypertension and Survival After Mitral Valve Surgery
    Kiefer, Todd L.
    Samad, Zainab
    Pomann, Gina-Marie
    Poon, Victor
    Shatila, Wassim
    Lokhnygina, Yuliya
    Velazquez, Eric J.
    Wang, Andrew
    CIRCULATION, 2016, 134
  • [30] The Association Between Post-Operative Pulmonary Hypertension and Survival After Mitral Valve Surgery
    Kiefer, Todd L.
    Samad, Zainab
    Pomann, Gina-Marie
    Poon, Victor
    Shatila, Wassim
    Lokhnygina, Yuliya
    Velazquez, Eric J.
    Wang, Andrew
    CIRCULATION, 2016, 134